Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r*,r*)-(+-)-2,3-dihydroxybutanedioic Acid, Monoammonium Monosodium Salt
2. Aluminum Tartrate
3. Ammonium Tartrate
4. Calcium Tartrate
5. Calcium Tartrate Tetrahydrate
6. Mn(iii) Tartrate
7. Potassium Tartrate
8. Seignette Salt
9. Sodium Ammonium Tartrate
10. Sodium Potassium Tartrate
11. Sodium Tartrate
12. Stannous Tartrate
13. Tartaric Acid
14. Tartaric Acid, ((r*,r*)-(+-))-isomer
15. Tartaric Acid, (r*,s*)-isomer
16. Tartaric Acid, (r-(r*,r*))-isomer
17. Tartaric Acid, (s-(r*,r*))-isomer
18. Tartaric Acid, Ammonium Sodium Salt, (1:1:1) Salt, (r*,r*)-(+-)-isomer
19. Tartaric Acid, Calcium Salt, (r-r*,r*)-isomer
20. Tartaric Acid, Monoammonium Salt, (r-(r*,r*))-isomer
21. Tartrate
1. Sodium Tartrate
2. 868-18-8
3. Disodium;2,3-dihydroxybutanedioate
4. Sodium 2,3-dihydroxysuccinate
5. 51307-92-7
6. Disodium 2,3-dihydroxybutanedioate
7. Disodium Tartrate Solution
8. Sodium-tartrate
9. Sodium Tartarate
10. Butanedioic Acid, 2,3-dihydroxy-, Sodium Salt (1:2), (2r,3r)-rel-
11. Sodium Tartrate Dibasic Solution
12. Sodium (2r,3r)-2,3-dihydroxysuccinate(x:1)
13. Butanedioic Acid, 2,3-dihydroxy-, Monosodium Salt, (2r,3r)-rel-
14. 14475-11-7
15. Schembl24913
16. Dl-tartaric Acid Disodium Salt
17. Chembl3917380
18. Sodium (dl)-(+/-)-tartrate
19. Akos006220952
20. Sb47841
21. As-56692
22. Db-056954
23. Ft-0632296
24. Ft-0633039
25. Sodium Tartrate Dibasic Solution, P.a., 99.5%
26. Q283499
27. Sodium Tartrate Dibasic Solution, Bioultra, 1.5 M In H2o (colorless Solution At 20 C)
| Molecular Weight | 194.05 g/mol |
|---|---|
| Molecular Formula | C4H4Na2O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 193.98032641 g/mol |
| Monoisotopic Mass | 193.98032641 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 123 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
A - Alimentary tract and metabolism
A06 - Drugs for constipation
A06A - Drugs for constipation
A06AD - Osmotically acting laxatives
A06AD21 - Sodium tartrate
Digital Content 
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Sodium Tartarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Tartarate, including repackagers and relabelers. The FDA regulates Sodium Tartarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Tartarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Tartarate supplier is an individual or a company that provides Sodium Tartarate active pharmaceutical ingredient (API) or Sodium Tartarate finished formulations upon request. The Sodium Tartarate suppliers may include Sodium Tartarate API manufacturers, exporters, distributors and traders.
Sodium Tartarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Tartarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Tartarate GMP manufacturer or Sodium Tartarate GMP API supplier for your needs.
A Sodium Tartarate CoA (Certificate of Analysis) is a formal document that attests to Sodium Tartarate's compliance with Sodium Tartarate specifications and serves as a tool for batch-level quality control.
Sodium Tartarate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Tartarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Tartarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Tartarate EP), Sodium Tartarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Tartarate USP).
LOOKING FOR A SUPPLIER?
